Vantage MedTech
Jim Bartel serves as the Chief Executive Officer and Board Member at Vantage MedTech since March 2024, leading a private equity-owned medical device company focused on the innovation and commercialization of medical technologies. Previously, Bartel held the role of Chief Executive Officer and Board Member at Waltek, Inc. from January 2020 to March 2024, overseeing a metal investment casting and machining company. Bartel's extensive experience in the medical device industry includes serving as President of Spectralytics Inc. at Cretex Medical and Chief Operations Officer at Precision ADM. Additional roles include senior positions at Stratasys, ATEK Companies, Miller Manufacturing Company, and Hot-Shot Products, with significant responsibilities in marketing, business development, and operational management. Bartel holds an MBA in Business, Management, and Marketing from the University of St. Thomas and additional qualifications from multiple educational institutions.
This person is not in any teams
Vantage MedTech
Vantage MedTech provides comprehensive design and manufacturing services, supporting the advancement of medical technologies from concept through to product realization. Partnering with the world’s most innovative MedTech start-ups and large medical device companies, we offer feasibility support, product development and prototyping, new product development, clinical and commercial manufacturing, and after-market services to support every phase of the product life cycle. Our clients can leverage our proprietary Advantage Platforms™, accelerating product development timelines. Our manufacturing approach is structured to serve the changing needs of our clients, supporting small-quantity clinical or First-in-Human builds and can scale to accommodate full launch quantities. Vantage MedTech has facilities in Moonachie, New Jersey and Lenexa, Kansas. Visit www.vantagemedtech.com for more information.